KalVista Pharmaceuticals Inc (NASDAQ:KALV) - Share price


Stock Report

KalVista Pharmaceuticals Inc KALV

Last Price
$14.82

Day Change
1.06|7.70%

As of 12/08/2022
17:57:13 EDT | USD
Minimum 15 Minutes Delay.

Last Close13.76
Day Range13.74 - 14.95
Mkt Cap364.10Mil
52-Wk Range8.00 - 21.77
Yield %-
ISINUS4834971032
Volume260,253
P/E-
P/S
P/CF-4.64

Share Price

Financials
202020212022
More ...
Income Statement
Revenue12.690.000.00
Operating Income-40.53-57.92-96.61
Net Income-29.12-46.24-82.34
Basic EPS-1.64-2.42-3.36
Avg. Diluted Shares Outstanding181924
Balance Sheet
Current Assets88.70264.26193.65
Non Current Assets3.837.7510.23
Total Assets92.53272.01203.88
Current Liabilities7.729.7711.58
Total Liabilities---
Total Equity83.75257.19185.09
Cash Flow
Operating Cash Flow-44.82-30.17-78.13
Capital Expenditure-0.22-0.08-0.93
Free Cash Flow-45.04-30.25-79.07

In millions, except "Basic EPS". Currency is USD.

Company Profile

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

April

Employees

105
Key Stats
More ...
Price/Earning TTM-4.10
Price/Book1.83
Price/Sales TTM
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-∞
Net Margin % TTM-∞
ROE TTM-37.23
Debt/Equity0.04
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.